Verax gets CE Mark clearance for platelet test

09/30/2008 | Pharmaceutical Business Review Online

Verax Biomedical has obtained European clearance for its Platelet PGD test, which is designed to rapidly spot bacterial contaminants in blood cells and tissue. The device, which has also secured 510(k) clearance from the FDA, could be used to boost the safety of the blood supply, the company said.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA